NO20002108L - Vasodilator - Google Patents

Vasodilator

Info

Publication number
NO20002108L
NO20002108L NO20002108A NO20002108A NO20002108L NO 20002108 L NO20002108 L NO 20002108L NO 20002108 A NO20002108 A NO 20002108A NO 20002108 A NO20002108 A NO 20002108A NO 20002108 L NO20002108 L NO 20002108L
Authority
NO
Norway
Prior art keywords
tissue
blood vessel
contrast agent
vessel dilating
perfusion
Prior art date
Application number
NO20002108A
Other languages
English (en)
Other versions
NO20002108D0 (no
Inventor
Morten Eriksen
Jonny Istensen
Sigmund Frigstad
Pol Rongved
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9722224.4A external-priority patent/GB9722224D0/en
Priority claimed from GBGB9809099.6A external-priority patent/GB9809099D0/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO20002108L publication Critical patent/NO20002108L/no
Publication of NO20002108D0 publication Critical patent/NO20002108D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Et kombinert preparat som innbefatter: i) et ultralydkontrastmiddel som kan akkumuleres i vevsmikrovaskulaturen og ii) en farmakologisk effektiv mengde av et blodkarutvidende medikament kan brukes ved perfusjonsavbildning, spesielt av myokardiet. Kontrastmidlet samler seg i vevet i konsentrasjoner som står i forhold til den regionale vevsperfusjonen, og det blodkarutvidende medikamentet forbedrer distinksjonen mellom normalt perfundert og underperfundert vev.
NO20002108A 1997-10-21 2000-04-25 Vasodilator NO20002108D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9722224.4A GB9722224D0 (en) 1997-10-21 1997-10-21 Improvements in or relating to ultrasound imaging
GBGB9809099.6A GB9809099D0 (en) 1998-04-28 1998-04-28 Improvements in or relating to ultrasound imaging
PCT/GB1998/003155 WO1999020312A1 (en) 1997-10-21 1998-10-21 Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug

Publications (2)

Publication Number Publication Date
NO20002108L true NO20002108L (no) 2000-04-25
NO20002108D0 NO20002108D0 (no) 2000-04-25

Family

ID=26312461

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002108A NO20002108D0 (no) 1997-10-21 2000-04-25 Vasodilator

Country Status (6)

Country Link
US (2) US6811766B1 (no)
EP (1) EP1024837A1 (no)
JP (1) JP2001520207A (no)
AU (1) AU9550498A (no)
NO (1) NO20002108D0 (no)
WO (1) WO1999020312A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263739B2 (en) 2000-06-02 2012-09-11 Bracco Suisse Sa Compounds for targeting endothelial cells, compositions containing the same and methods for their use
EP2279757A3 (en) 2000-06-02 2011-08-03 Bracco Suisse SA Compounds for targeting endothelial cells
NO20010234D0 (no) * 2001-01-12 2001-01-12 Nycomed Imaging As Perfusjon avbildningsbilde
DK1590006T3 (da) 2003-02-04 2010-12-20 Bracco Suisse Sa Ultralydskontrastmidler og fremgangsmåde til frembringelse deraf
JP4473543B2 (ja) * 2003-09-05 2010-06-02 株式会社東芝 超音波診断装置
WO2005063305A1 (en) 2003-12-22 2005-07-14 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US9248204B2 (en) 2004-08-18 2016-02-02 Bracco Suisse S.A. Gas-filled microvesicles composition for contrast imaging
EA011516B1 (ru) 2005-01-13 2009-04-28 Синвеншен Аг Композиционный материал и способ его изготовления
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
CA2624906A1 (en) * 2005-10-18 2007-04-26 Cinvention Ag Thermoset particles and methods for production thereof
US20080177220A1 (en) * 2006-01-06 2008-07-24 The Curators Of The University Of Missouri Ultrasound-Mediated Transcleral Drug Delivery
US20090062724A1 (en) * 2007-08-31 2009-03-05 Rixen Chen System and apparatus for sonodynamic therapy
GB0811856D0 (en) 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
US8192364B2 (en) * 2009-06-10 2012-06-05 Mayo Foundation For Medical Education And Research Method for assessing vascular disease by quantitatively measuring vaso vasorum
WO2021255025A1 (en) * 2020-06-15 2021-12-23 Bracco Suisse Sa Improvements in ultrasound-mediated therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972890A (en) * 1988-05-02 1999-10-26 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5117830A (en) * 1990-11-08 1992-06-02 Whitby Research, Inc. Method of determining viability of tissue
US5846516A (en) * 1992-06-03 1998-12-08 Alliance Pharmaceutial Corp. Perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications
EP1550464A1 (en) * 1993-07-30 2005-07-06 IMCOR Pharmaceutical Co. Stabilized microbubble composition for ultrasound
EP0831932B1 (en) * 1995-06-07 2004-05-06 Imarx Pharmaceutical Corp. Novel targeted compositions for diagnostic and therapeutic use
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
DE69738406T2 (de) * 1996-10-21 2008-12-04 Ge Healthcare As Verbesserungen in oder an Kontrastmitteln
WO1998018501A2 (en) * 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents
WO1998018498A2 (en) * 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents
WO1998040285A1 (en) 1997-03-13 1998-09-17 Minnesota Mining And Manufacturing Company Sample package

Also Published As

Publication number Publication date
US20040230122A1 (en) 2004-11-18
JP2001520207A (ja) 2001-10-30
EP1024837A1 (en) 2000-08-09
AU9550498A (en) 1999-05-10
NO20002108D0 (no) 2000-04-25
WO1999020312A1 (en) 1999-04-29
US6811766B1 (en) 2004-11-02

Similar Documents

Publication Publication Date Title
NO20002108L (no) Vasodilator
DK1323434T3 (da) Fremgangsmåde til diagnostisk billeddannelse af nyreregioner under anvendelse af et kontrastmiddel og en vasodilator
ATE375806T1 (de) Verbesserungen in oder bezüglich zu kontrastmittel
WO2004017907A3 (en) Blood clot-targeted nanoparticles
EP1543141A4 (en) Quantitative rt-pcr to ac133 to diagnose cancer and monitor angiogenic activity in a cell sample
IS2788B (is) Búdesóníð- / formóterólefnablanda til innöndunar með lausa þéttni frá 0,30 til 0,36 g/ml, aðferð við að framleiða efnablönduna og notkun hennar
NO974071D0 (no) Orale, farmasöytiske doseringsformer omfattende en protonpumpeinhibitor og et syrenöytraliserende middel eller alginat
ATE75372T1 (de) Emulsionskonzentrate von bioziden substanzen, erhaltene waessrige mikroemulsionen und anwendung dieser mikroemulsionen zur holzbehandlung.
NO996323D0 (no) Medisinske blandinger for anvendelse på mukosa
ITRM20000089A0 (it) Catodo attivato e procedimento per la sua preparazione.
RU99124771A (ru) Применение альфа-метил-п-тирозина для ингибирования продуцирования меланина в меланоцитах радужной оболочки
MA26777A1 (fr) Inhibiteurs d'aminotransferase dependante d'aminoacide en chaine ramifiee et leur usage dans le traitement de la retinopathie diabetique.
PT92647A (pt) Processo para a preparacao de 5-cloro-2-< { (3,4-dimetoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
DK0918469T3 (da) Fremgangsmåder og præparater til at øge den vævsanaerobe arbejdskapacitet
FR2773712B1 (fr) Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a
RU96114157A (ru) Способ лечения острых отравлений
NO20015487L (no) Oppfangingsmiddel for karbonylforbindelser i blod
FR2804601B1 (fr) Dispositif d'application de principes actifs utilisables dans le domaine pharmaceutique ou cosmetique
TR200202103T2 (tr) ''5-[{6-(2-Flüorobenzil)oksi-2-naftil}metil]-2,4-tiyazolidin dion kristalleri''
EP1297838A4 (en) PRALMORELIN-CONTAINED NOSE DROP PREPARATIONS
RU95108344A (ru) Способ оценки эффективности лечения ишемической болезни сердца
RU94039553A (ru) Средство для лечения хронического простатита
EA200100164A1 (ru) Применение усилителя захвата глюкозы для уменьшения постишемического повреждения сердца
吴效明 et al. TAPERED EFFECTS OF NONLINEAR BLOOD FLOW IN AN ARTERY

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application